节点文献

斯奇康佐治常年性变应性鼻炎的临床评价

Clinical evaluation of Skiller kang george perennial allergic rhinitis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 崔玲宋杰赵黎阳

【Author】 CUI Ling,SONG Jie,ZHAO Liyang The Friendship Hospital of Dalian City,Liaoning Province,Dalian 116011,China

【机构】 大连市友谊医院

【摘要】 目的:斯奇康注射液治疗常年性变应性鼻炎的疗效观察与评价。方法:83例患者,随机分为两组,治疗组局部鼻腔应用鼻用类固醇(辅舒良)联合应用斯奇康注射液;对照组单纯局部鼻腔应用鼻用类固醇(辅舒良)。结论:两组对比指标为临床症状及血清IgE变化。停止治疗1个月,两组对比指标差异无统计学意义(P>0.05);停止治疗2个月、3个月后两组对比指标差异有统计学意义(P<0.05)。结果:斯奇康注射液佐治常年性变应性鼻炎的疗效值得肯定。

【Abstract】 Objective: To observe efficacy and evaluation of Siqikang injection in the treatment of perennial allergic rhinitis.Methods: 83 patients were randomly divided into two groups,the treatment group of local intranasal nasal steroids(Fu Shu Liang) combined Siqikang injection;the control group were treated with partial nasal nasal steroids(Fu Shu Liang).Conclusion: Indicators of clinical symptoms and changes in serum IgE between two groups.1 month of treatment cessation,the two groups showed no statistically significant indicator(P>0.05);stop for 2,3 months,the index difference between two groups was significant(P<0.05).Results: Siqikang injection treating perennial allergic rhinitis is affirmative.

【关键词】 斯奇康变应性鼻炎鼻用类固醇
【Key words】 BCG-PSNAllergic rhinitisNasal steroids
  • 【文献出处】 中国当代医药 ,China Modern Medicine , 编辑部邮箱 ,2011年11期
  • 【分类号】R765.21
  • 【下载频次】22
节点文献中: 

本文链接的文献网络图示:

本文的引文网络